M D Hill P A Barber A M Demchuk R J Sevick R Frayne A M Buchan
10.1186/1471-2377-1-1
BMC Neurol
2001 Dec 18;1:1.
NO-CC CODE
https://pubmed.ncbi.nlm.nih.gov/11208259/
Brain Ischemia / diagnosis Intracranial Hemorrhages / chemically induced Intracranial Hemorrhages / diagnosis Stroke / complications Tissue Plasminogen Activator / adverse effects
Brain Ischemia / diagnosis Intracranial Hemorrhages / chemically induced Intracranial Hemorrhages / diagnosis Stroke / complications Tissue Plasminogen Activator / adverse effects Case Reports Research Support, Non-U.S. Gov't Aged Diagnosis, Differential Fatal Outcome Fibrinolytic Agents / adverse effects Fibrinolytic Agents / therapeutic use Humans Intracranial Hemorrhages / diagnostic imaging Magnetic Resonance Imaging Male Muscle Weakness / etiology Stroke / drug therapy Tissue Plasminogen Activator / therapeutic use Tomography, X-Ray Computed Fibrinolytic Agents Tissue Plasminogen Activator
PMC29099
11208259
Symptomatic hemorrhage after alteplase therapy not due to silent ischemia
2001